CRSP Stock-Based Compensation
Crispr Therapeutics Ag · Stock-Based Compensation
CRSP Stock-Based Compensation
Latest reported$68.32Mperiod ending
CRSP Stock-Based Comp ($695.00K → $68.32M)
Annual stock-based compensation
High-resolution chart · PNG
CRSP stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 72,499,000 | |
| 86,567,000 | |
| 81,028,000 | |
| 97,947,000 | |
| 102,390,000 | |
| 66,018,000 | |
| 44,057,000 | |
| 34,985,000 | |
| 18,873,000 | |
| 10,844,000 | |
| 3,684,000 | |
| 695,000 |